Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Butylscopolamine is an antispasmodic and anticholinergic agent used for the symptomatic treatment of abdominal cramping and pain. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system.
- Mechanism
- Curator reviewed · 1 reference
Scopolamine butylbromide binds to muscarinic M3 receptors in the gastrointestinal tract. This prevents acetycholine from binding to and activating the receptors which would result in contraction of the smooth muscle. The inhibition of contraction reduces spasms and their related pain during abdominal cramping.
- Primary indication
- Used to treat abdmoninal cramping and pain.Curator reviewed · 22 structured indications
- Formula / weight
- C21H30NO4 · 360.473 g/mol (avg)
- First approval
- Canada, 2007
- Also known as
- N-butylscopolammonium · N-butylscopolammonium ion
- Brand names
- Buscopan
Resolves to
YBCNXCRZPWQOBR-WVHCHWADSA-NSMILESCCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1What you can answer from here — as of September 21, 2026
Which drugs share a target with Butylscopolamine, and which of those have an active Phase 3 trial?